Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.

Steeb T, Heppt MV, Berking C.

Br J Dermatol. 2020 Apr 5. doi: 10.1111/bjd.19036. [Epub ahead of print] No abstract available.

PMID:
32249410
2.

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.

Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C.

J Dtsch Dermatol Ges. 2020 Apr 4. doi: 10.1111/ddg.14072. [Epub ahead of print]

PMID:
32247292
3.

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.

Amaral T, Kiecker F, Schaefer S, Stege H, Kaehler K, Terheyden P, Gesierich A, Gutzmer R, Haferkamp S, Uttikal J, Berking C, Rafei-Shamsabadi D, Reinhardt L, Meier F, Karoglan A, Posch C, Gambichler T, Pfoehler C, Thoms K, Tietze J, Debus D, Herbst R, Emmert S, Loquai C, Hassel JC, Meiss F, Tueting T, Heinrich V, Eigentler T, Garbe C, Zimmer L; *German Dermatological Cooperative Oncology Group.

J Immunother Cancer. 2020 Mar;8(1). pii: e000333. doi: 10.1136/jitc-2019-000333.

4.

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.

Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C.

J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294. doi: 10.1111/ddg.14048.

PMID:
32130773
5.

S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren.

Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C.

J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294. doi: 10.1111/ddg.14048_g. German.

PMID:
32130769
6.

Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence.

Steeb T, Wessely A, Heppt F, Harlaß M, Berking C, Heppt MV.

Br J Dermatol. 2020 Feb 18. doi: 10.1111/bjd.18957. [Epub ahead of print] No abstract available.

PMID:
32068244
7.

Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.

Gutzmer R, Wiegand S, Kölbl O, Wermker K, Heppt M, Berking C.

Dtsch Arztebl Int. 2019 Sep 13;116(37):616-626. doi: 10.3238/arztebl.2019.0616.

8.

Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument.

Steeb T, Hayani KM, Förster P, Liegl R, Toussaint F, Schlaak M, Berking C, Heppt MV.

J Cancer Res Clin Oncol. 2020 Apr;146(4):1079-1088. doi: 10.1007/s00432-020-03141-w. Epub 2020 Feb 8.

9.

The Role of Immune Checkpoint Blockade in Uveal Melanoma.

Wessely A, Steeb T, Erdmann M, Heinzerling L, Vera J, Schlaak M, Berking C, Heppt MV.

Int J Mol Sci. 2020 Jan 29;21(3). pii: E879. doi: 10.3390/ijms21030879. Review.

10.

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, Schadendorf D, Guminski A, Hauschild A, Wong DJ, Daniels GA, Berking C, Jankovic V, Stankevich E, Booth J, Li S, Weinreich DM, Yancopoulos GD, Lowy I, Fury MG, Rischin D.

Lancet Oncol. 2020 Feb;21(2):294-305. doi: 10.1016/S1470-2045(19)30728-4. Epub 2020 Jan 14.

PMID:
31952975
11.

Microneedling-assisted photodynamic therapy for the treatment of actinic keratosis: Results from a systematic review and meta-analysis.

Steeb T, Niesert AC, French LE, Berking C, Heppt MV.

J Am Acad Dermatol. 2020 Feb;82(2):515-519. doi: 10.1016/j.jaad.2019.09.037. No abstract available.

PMID:
31928689
12.

Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial Tumors.

Kirchberger MC, Heppt MV, Schuler G, Berking C, Heinzerling L.

Facial Plast Surg. 2019 Dec 30. doi: 10.1055/s-0039-3401805. [Epub ahead of print]

PMID:
31887750
13.

Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review.

Heppt MV, Steeb T, Berking C, Nast A.

J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:25-32. doi: 10.1111/jdv.15846. Review.

PMID:
31833609
14.

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study.

Heppt MV, Amaral T, Kähler KC, Heinzerling L, Hassel JC, Meissner M, Kreuzberg N, Loquai C, Reinhardt L, Utikal J, Dabrowski E, Gesierich A, Pföhler C, Terheyden P, Thoms KM, Zimmer L, Eigentler TK, Kirchberger MC, Stege HM, Meier F, Schlaak M, Berking C.

J Immunother Cancer. 2019 Nov 13;7(1):299. doi: 10.1186/s40425-019-0800-0.

15.

Corrigendum to 'Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data' [Eur J Cancer, 119 (September 2019) Pages 30-34].

Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, French LE, Berking C, Schilling B, Haferkamp S, Fröhling S, von Kalle C, Brinker TJ.

Eur J Cancer. 2019 Dec;123:171. doi: 10.1016/j.ejca.2019.10.003. Epub 2019 Nov 7. No abstract available.

16.

Comparative analysis of the phototoxicity induced by BRAF inhibitors and alleviation through antioxidants.

Heppt MV, Clanner-Engelshofen BM, Marsela E, Wessely A, Kammerbauer C, Przybilla B, French LE, Berking C, Reinholz M.

Photodermatol Photoimmunol Photomed. 2020 Mar;36(2):126-134. doi: 10.1111/phpp.12520. Epub 2019 Nov 11.

PMID:
31618797
17.

Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.

Heppt MV, Steeb T, Schmitz L, Garbe C, French LE, Leiter U, Berking C.

Trials. 2019 Oct 11;20(1):589. doi: 10.1186/s13063-019-3696-6.

18.

Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.

Steeb T, Heppt MV, Becker L, Kohl C, French LE, Berking C.

Syst Rev. 2019 Oct 11;8(1):237. doi: 10.1186/s13643-019-1156-8.

19.

The more the better? An appraisal of combination therapies for actinic keratosis.

Steeb T, Wessely A, Leiter U, French LE, Berking C, Heppt MV.

J Eur Acad Dermatol Venereol. 2020 Apr;34(4):727-732. doi: 10.1111/jdv.15998. Epub 2019 Nov 11. Review.

PMID:
31587385
20.

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.

Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer NH, Berking C, Sunderkötter C, Kaatz M, Schatton K, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Verver D, Martus P, Garbe C; German Dermatologic Cooperative Oncology Group.

J Clin Oncol. 2019 Nov 10;37(32):3000-3008. doi: 10.1200/JCO.18.02306. Epub 2019 Sep 26.

PMID:
31557067
21.

Superior skin cancer classification by the combination of human and artificial intelligence.

Hekler A, Utikal JS, Enk AH, Hauschild A, Weichenthal M, Maron RC, Berking C, Haferkamp S, Klode J, Schadendorf D, Schilling B, Holland-Letz T, Izar B, von Kalle C, Fröhling S, Brinker TJ; Collaborators.

Eur J Cancer. 2019 Oct;120:114-121. doi: 10.1016/j.ejca.2019.07.019. Epub 2019 Sep 10.

22.

Möglichkeiten und Grenzen von prognostischen Gensignaturen im frühen Melanom.

Heppt MV, Berking C.

J Dtsch Dermatol Ges. 2019 Aug;17(8):769-770. doi: 10.1111/ddg.13901_g. German. No abstract available.

PMID:
31437361
23.

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks.

Maron RC, Weichenthal M, Utikal JS, Hekler A, Berking C, Hauschild A, Enk AH, Haferkamp S, Klode J, Schadendorf D, Jansen P, Holland-Letz T, Schilling B, von Kalle C, Fröhling S, Gaiser MR, Hartmann D, Gesierich A, Kähler KC, Wehkamp U, Karoglan A, Bär C, Brinker TJ; Collabrators.

Eur J Cancer. 2019 Sep;119:57-65. doi: 10.1016/j.ejca.2019.06.013. Epub 2019 Aug 14.

24.

Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data.

Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, French LE, Berking C, Schilling B, Haferkamp S, Fröhling S, von Kalle C, Brinker TJ.

Eur J Cancer. 2019 Sep;119:30-34. doi: 10.1016/j.ejca.2019.07.009. Epub 2019 Aug 8. Erratum in: Eur J Cancer. 2019 Dec;123:171.

25.

Deep neural networks are superior to dermatologists in melanoma image classification.

Brinker TJ, Hekler A, Enk AH, Berking C, Haferkamp S, Hauschild A, Weichenthal M, Klode J, Schadendorf D, Holland-Letz T, von Kalle C, Fröhling S, Schilling B, Utikal JS.

Eur J Cancer. 2019 Sep;119:11-17. doi: 10.1016/j.ejca.2019.05.023. Epub 2019 Aug 8.

26.

A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging.

Brunner G, Heinecke A, Falk TM, Ertas B, Blödorn-Schlicht N, Schulze HJ, Suter L, Atzpodien J, Berking C.

JNCI Cancer Spectr. 2018 Jul 23;2(3):pky032. doi: 10.1093/jncics/pky032. eCollection 2018 Jul.

27.

Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma.

Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt MV, Bürdek M, Berking C, Prinz JC.

Front Immunol. 2019 Jun 18;10:1336. doi: 10.3389/fimmu.2019.01336. eCollection 2019.

28.

Photodynamic therapy 'to go' - a strengths, weaknesses, opportunities and threats analysis.

Heppt MV, Steeb T, Berking C.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e447-e449. doi: 10.1111/jdv.15772. Epub 2019 Jul 16. No abstract available.

PMID:
31273846
29.

Patient Attitudes and Their Awareness Towards Skin Cancer-Related Apps: Cross-Sectional Survey.

Steeb T, Wessely A, Mastnik S, Brinker TJ, French LE, Niesert AC, Berking C, Heppt MV.

JMIR Mhealth Uhealth. 2019 Jul 2;7(7):e13844. doi: 10.2196/13844.

30.

Informations- und Hilfsangebote für Melanompatienten: Präferenzielle Unterschiede zwischen Patienten und Ärzten.

Brütting J, Bergmann M, Schadendorf D, Weber C, Tilgen W, Berking C, Meier F; im Auftrag der NVKH.

J Dtsch Dermatol Ges. 2019 Jun;17(6):652-654. doi: 10.1111/ddg.13831_g. No abstract available.

PMID:
31241828
31.

Skin Cancer Smartphone Applications for German-speaking Patients: Review and Content Analysis Using the Mobile App Rating Scale.

Steeb T, Wessely A, French LE, Heppt MV, Berking C.

Acta Derm Venereol. 2019 Oct 1;99(11):1043-1044. doi: 10.2340/00015555-3240. No abstract available.

32.

Pathologist-level classification of histopathological melanoma images with deep neural networks.

Hekler A, Utikal JS, Enk AH, Berking C, Klode J, Schadendorf D, Jansen P, Franklin C, Holland-Letz T, Krahl D, von Kalle C, Fröhling S, Brinker TJ.

Eur J Cancer. 2019 Jul;115:79-83. doi: 10.1016/j.ejca.2019.04.021. Epub 2019 May 23.

33.

Conceptual, statistical and clinical interpretation of results from: Cryosurgery combined with topical interventions for actinic keratosis: reply from the authors.

Heppt MV, Steeb T, Berking C.

Br J Dermatol. 2019 Aug;181(2):424-425. doi: 10.1111/bjd.18039. Epub 2019 May 15. No abstract available.

PMID:
31021410
34.

Patient Attitude towards Videodermatoscopy for the Detection of Skin Cancer: A Cross-Sectional Study.

Steeb T, Wessely A, Niesert AC, Ruzicka T, von Braunmühl T, Berking C, Heppt MV.

Oncol Res Treat. 2019;42(6):319-325. doi: 10.1159/000499630. Epub 2019 Apr 17.

PMID:
30995670
35.

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C; Collaborators.

Eur J Cancer. 2019 May;113:47-54. doi: 10.1016/j.ejca.2019.04.001. Epub 2019 Apr 10.

36.

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma.

van Herpen CML, Agarwala SS, Hauschild A, Berking C, Beck JT, Schadendorf D, Jansen R, Queirolo P, Ascierto PA, Blank CU, Heinrich MC, Pal RR, Derti A, Antona V, Nauwelaerts H, Zubel A, Dummer R.

Oncotarget. 2019 Mar 5;10(19):1850-1859. doi: 10.18632/oncotarget.26753. eCollection 2019 Mar 5.

37.

Sources of information and support for melanoma patients: differences between patients' and clinicians' preferences.

Brütting J, Bergmann M, Schadendorf D, Weber C, Tilgen W, Berking C, Meier F; NVKH.

J Dtsch Dermatol Ges. 2019 Jun;17(6):652-654. doi: 10.1111/ddg.13831. Epub 2019 Apr 1. No abstract available.

PMID:
30933429
38.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Fröhling S, Utikal JS, von Kalle C; Collaborators.

Eur J Cancer. 2019 Apr;111:148-154. doi: 10.1016/j.ejca.2019.02.005. Epub 2019 Mar 8.

39.

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark.

Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, Karoglan A, von Kalle C, Weichenthal M, Sattler E, Schadendorf D, Gaiser MR, Klode J, Utikal JS.

Eur J Cancer. 2019 Apr;111:30-37. doi: 10.1016/j.ejca.2018.12.016. Epub 2019 Feb 22.

40.

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.

Rauschenberg R, Bruns J, Brütting J, Daubner D, Lohaus F, Zimmer L, Forschner A, Zips D, Hassel JC, Berking C, Kaehler KC, Utikal J, Gutzmer R, Terheyden P, Meiss F, Rafei-Shamsabadi D, Kiecker F, Debus D, Dabrowski E, Arnold A, Garzarolli M, Kuske M, Beissert S, Löck S, Linn J, Troost EGC, Meier F.

Eur J Cancer. 2019 Mar;110:11-20. doi: 10.1016/j.ejca.2018.12.023. Epub 2019 Feb 7.

41.

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.

Shannan B, Matschke J, Chauvistré H, Vogel F, Klein D, Meier F, Westphal D, Bruns J, Rauschenberg R, Utikal J, Forschner A, Berking C, Terheyden P, Dabrowski E, Gutzmer R, Rafei-Shamsabadi D, Meiss F, Heinzerling L, Zimmer L, Livingstone E, Váraljai R, Hoewner A, Horn S, Klode J, Stuschke M, Scheffler B, Marchetto A, Sannino G, Grünewald TGP, Schadendorf D, Jendrossek V, Roesch A.

Eur J Cancer. 2019 Mar;109:137-153. doi: 10.1016/j.ejca.2018.12.024. Epub 2019 Feb 2.

PMID:
30721788
42.

Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis.

Heppt MV, Steeb T, Leiter U, Berking C.

J Eur Acad Dermatol Venereol. 2019 May;33(5):863-873. doi: 10.1111/jdv.15459. Epub 2019 Mar 1.

PMID:
30710390
43.
44.

Exploring the Most Visible German Websites on Melanoma Immunotherapy: A Web-Based Analysis.

Brütting J, Steeb T, Reinhardt L, Berking C, Meier F.

JMIR Cancer. 2018 Dec 13;4(2):e10676. doi: 10.2196/10676.

45.

The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.

Graf SA, Heppt MV, Wessely A, Krebs S, Kammerbauer C, Hornig E, Strieder A, Blum H, Bosserhoff AK, Berking C.

Pigment Cell Melanoma Res. 2019 May;32(3):424-434. doi: 10.1111/pcmr.12760. Epub 2018 Dec 21.

PMID:
30506895
46.

Targeted Therapy of Melanoma.

Berking C.

J Investig Dermatol Symp Proc. 2018 Dec;19(2):S86. doi: 10.1016/j.jisp.2018.09.009.

47.

Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.

Heppt MV, Steeb T, Ruzicka T, Berking C.

Br J Dermatol. 2019 Apr;180(4):740-748. doi: 10.1111/bjd.17435. Epub 2018 Dec 27. Review.

PMID:
30447074
48.

Teledermatology: Comparison of Store-and-Forward Versus Live Interactive Video Conferencing.

Brinker TJ, Hekler A, von Kalle C, Schadendorf D, Esser S, Berking C, Zacher MT, Sondermann W, Grabe N, Steeb T, Utikal JS, French LE, Enk AH.

J Med Internet Res. 2018 Oct 24;20(10):e11871. doi: 10.2196/11871.

49.

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study.

Tietze JK, Forschner A, Loquai C, Mitzel-Rink H, Zimmer L, Meiss F, Rafei-Shamsabadi D, Utikal J, Bergmann M, Meier F, Kreuzberg N, Schlaak M, Weishaupt C, Pföhler C, Ziemer M, Fluck M, Rainer J, Heppt MV, Berking C.

Oncotarget. 2018 Sep 28;9(76):34336-34346. doi: 10.18632/oncotarget.26149. eCollection 2018 Sep 28.

50.

Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.

Brinker TJ, Hekler A, Utikal JS, Grabe N, Schadendorf D, Klode J, Berking C, Steeb T, Enk AH, von Kalle C.

J Med Internet Res. 2018 Oct 17;20(10):e11936. doi: 10.2196/11936.

Supplemental Content

Loading ...
Support Center